Ramazan Sarı

Finerenone Use in Heart Failure Patients with Type 2 Diabetes and Kidney Disease: An Analysis of the FINE-TURK Registry.

BACKGROUND Finerenone, a non-steroidal mineralocorticoid receptor antagonist, improves cardiorenal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease. However, real-world data on its use in patients with concomitant heart failure remain limited. This study aimed to evaluate the baseline chara...

Long-Term Outcomes and Predictors of Recurrent Weight Gain After Sleeve Gastrectomy, Roux-En-Y Gastric Bypass, and One Anastomosis Gastric Bypass: Turkish Metabolic and Bariatric Surgery Follow-up Study (TMBS Study).

Evolution of thyroid fine-needle aspiration biopsy performance over 15 years: implications for risk stratification in clinical practice

Objective We aimed to evaluate temporal changes in the diagnostic performance of thyroid fine-needle aspiration biopsy (FNAB) over a 15-year period in a single-center, surgically confirmed cohort. Subjects and methods We retrospectively analyzed thyroid FNABs performed between 2009 and 2023, dividing the data into two...

EP1743 - LBA_ECE_1356 - Coronary heart disease in patients with type 2 biabetes: the role of traditional, behavioral and atherogenic risk factors in a large multicenter study

In this large national cohort of T2DM patients, CAD was independently associated with classical cardiometabolic risk factors, microvascular complications, and lower income, whereas lifestyle factors were not independently associated after adjustment.